Management of Severe Hypertension in Alcohol Withdrawal with Hypertrophic Cardiomyopathy
Use benzodiazepines as first-line therapy to treat the alcohol withdrawal syndrome itself, which will simultaneously address the hypertension, and add a nonvasodilating beta-blocker (e.g., metoprolol, atenolol) if blood pressure remains severely elevated despite adequate benzodiazepine dosing. 1, 2
Immediate Management Approach
Step 1: Treat the Underlying Alcohol Withdrawal
The hypertension in this scenario is primarily driven by the hyperadrenergic state of alcohol withdrawal. Benzodiazepines are the gold standard for alcohol withdrawal syndrome and will reduce both withdrawal symptoms AND blood pressure by dampening sympathetic overactivity 1. Use a symptom-triggered regimen with CIWA-Ar scoring:
- CIWA-Ar >8: Moderate withdrawal requiring treatment
- CIWA-Ar ≥15: Severe withdrawal requiring aggressive treatment
For patients with HCM and hepatic dysfunction (common in alcohol use disorder), use lorazepam or oxazepam (short/intermediate-acting) rather than diazepam, as they are safer with liver impairment 1.
Step 2: Add Beta-Blocker if Hypertension Persists
If blood pressure remains in the 200s despite adequate benzodiazepine therapy, add a nonvasodilating beta-blocker 2. This is the preferred first-line agent for HCM and has the dual benefit of:
- Reducing heart rate and contractility (beneficial for HCM)
- Lowering blood pressure without worsening outflow obstruction
- Counteracting the hyperadrenergic state of withdrawal
Titrate to physiologic effect (resting heart rate suppression), not just to a predetermined dose 2.
Step 3: Consider Non-Dihydropyridine Calcium Channel Blockers as Alternative
If beta-blockers are contraindicated or not tolerated, verapamil or diltiazem are reasonable alternatives 2. These have the added benefit of treating both HCM symptoms and hypertension 2. However, avoid verapamil if the patient has severe dyspnea at rest, hypotension, or very high resting gradients (>100 mmHg) 2.
Importantly, the 2024 AHA/ACC guidelines note that calcium channel blockers "may have a role in management of concomitant hypertension" even when combined with beta-blockers 2.
Critical Medications to AVOID
Absolutely discontinue or avoid the following in HCM patients 2:
- ACE inhibitors (worsen outflow obstruction via vasodilation)
- ARBs (worsen outflow obstruction via vasodilation)
- Dihydropyridine calcium channel blockers (e.g., amlodipine, nifedipine - pure vasodilators)
- High-dose diuretics (decrease preload, worsen obstruction)
- Digoxin (positive inotrope, worsens obstruction)
These vasodilators can precipitate acute hemodynamic collapse in obstructive HCM by reducing afterload and preload, thereby increasing the outflow gradient 2.
If Acute Hypotension Develops
Should the patient become hypotensive (a medical emergency in HCM), immediately administer intravenous phenylephrine or other pure vasoconstrictors WITHOUT inotropic activity 2, 3, 2. This is a Class 1 recommendation. Combine with beta-blockade to dampen contractility and prolong diastolic filling 2.
Maximize preload and afterload while avoiding increases in contractility or heart rate 2.
Nuances and Common Pitfalls
The HCM-Specific Challenge
Standard hypertensive urgency management relies heavily on vasodilators, which are contraindicated in obstructive HCM. The 2024 guidelines explicitly state to "eliminate medications that may promote outflow tract obstruction, such as pure vasodilators" 2.
Alcohol Withdrawal Hypertension is Self-Limited
Research shows that hypertension in alcohol withdrawal is typically self-limited 4, but treatment is crucial to prevent hypertensive urgency/emergency. The first 24 hours are most critical, particularly in patients with underlying treatment-resistant hypertension 4.
Don't Overtreat Asymptomatic Severe Hypertension
A blood pressure of 200 systolic without end-organ damage does NOT require immediate aggressive reduction 5. Rapid lowering can cause ischemic brain damage. Gentle lowering with careful surveillance is key 5. The goal is NOT to normalize blood pressure immediately but to prevent complications while treating the underlying withdrawal.
Diuretics: Use Cautiously
If there is clinical evidence of volume overload and high left-sided filling pressures despite other therapy, cautious use of LOW-DOSE oral diuretics may be considered 2. However, aggressive diuresis decreases preload and can augment LVOT obstruction 2.
Monitoring Strategy
- Assess for end-organ damage: Check for hypertensive emergency (encephalopathy, acute coronary syndrome, acute heart failure, aortic dissection) 4
- Serial CIWA-Ar scores: Guide benzodiazepine dosing
- Continuous telemetry: Monitor for arrhythmias
- Frequent vital signs: Every 1-2 hours initially
- Echocardiography: If not recently performed, assess for LVOT gradient and degree of obstruction
Long-Term Considerations
Once the acute withdrawal resolves, reassess blood pressure control. If hypertension persists, continue beta-blockers or non-dihydropyridine calcium channel blockers as they serve dual purposes for both HCM and hypertension 2, 6. A retrospective study of 115 HCM patients with coexisting hypertension showed that stepwise, symptom-oriented therapy successfully reduced uncontrolled hypertension from 56% to 37% while improving HCM symptoms 6.